Late acute thrombosis after paclitaxel eluting stent implantation

F Liistro1, A Colombo

  • 1Cardiac Catheterisation Laboratory, San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy. francescoliistro@hotmail.com

Insights

Late total occlusion after coronary stenting can occur over six months post-procedure. This case highlights a thrombotic event after paclitaxel drug-eluting stent implantation, suggesting ongoing risks.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Late total occlusion (LTO) after coronary stenting, typically >6 months, affects ~4% of patients, often due to intimal hyperplasia.
  • Coronary stenting with brachytherapy has shown higher LTO rates, linked to stent thrombosis rather than hyperplasia.
  • Paclitaxel drug-eluting stents (DES) are widely used to reduce restenosis.

Observation:

  • A case of LTO presenting with an acute clinical event seven months after paclitaxel-eluting stent implantation.
  • The occlusion occurred shortly after the interruption of ticlopidine treatment, an antiplatelet medication.

Findings:

  • The clinical presentation and timing suggest a thrombotic genesis for the LTO, challenging the assumption of intimal hyperplasia as the sole cause.
  • This case indicates that the risk of stent thrombosis leading to LTO may extend beyond the initial six-month period post-DES implantation.

Implications:

  • The findings suggest that prolonged antiplatelet therapy might be crucial even after six months in specific patient subsets with DES.
  • Further research is needed to understand the mechanisms and risk factors for late stent thrombosis and LTO after DES implantation.
  • This case underscores the importance of considering thrombotic events in the differential diagnosis of late stent failure.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...